Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects
- PMID: 3540008
- PMCID: PMC424020
- DOI: 10.1172/JCI112782
Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects
Abstract
Kininogenase activity was detected by cleavage of radiolabeled substrate (125I-high molecular weight kininogen [HMWK]) in 22 of 24 bronchoalveolar lavage (BAL) fluid samples from 17 asthmatics who either responded to aerosolized allergen challenge or had symptoms of active asthma. In contrast, six of seven normal controls lacked enzymatic activity. Levels of free immunoreactive kinin found in BAL fluid correlated with the presence of kininogenase activity (P = 0.002). The cleavage pattern of 125I-HMWK by the BAL fluid kininogenase (a dominant 65,000-mol wt fragment), and synthetic inhibitor profile (phe-phe-arg-CH2Cl and phenylmethylsulfonyl fluoride) were compatible with a tissue kallikrein. Peak kininogenase activity eluted at an apparent molecular weight of 20,000-34,000 by HPLC gel filtration. Its antigenic identity was established by immunoblotting with anti-human urinary kallikrein antibody and its activity was inhibited by this antibody. Lysylbradykinin was generated during incubation of fractionated BAL fluid and purified HMWK, the characteristic cleavage product of the tissue kallikreins. We conclude that elevated amounts of tissue kallikrein and kinin are present in the bronchoalveolar spaces of asthmatic subjects. Kinin generation may contribute to the asthmatic response directly through edema formation and smooth muscle contraction and by augmenting release and/or production of preformed (histamine) and secondary mediators such as leukotrienes and platelet-activating factor.
Similar articles
-
Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge.Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):900-5. doi: 10.1164/ajrccm/145.4_Pt_1.900. Am Rev Respir Dis. 1992. PMID: 1554219
-
Inhibition of human bronchial kallikrein in asthma.Am Rev Respir Dis. 1989 May;139(5):1125-31. doi: 10.1164/ajrccm/139.5.1125. Am Rev Respir Dis. 1989. PMID: 2785358
-
Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.Proc Natl Acad Sci U S A. 1983 Jul;80(13):3928-32. doi: 10.1073/pnas.80.13.3928. Proc Natl Acad Sci U S A. 1983. PMID: 6575386 Free PMC article.
-
Kinin formation: mechanisms and role in inflammatory disorders.Annu Rev Immunol. 1988;6:49-83. doi: 10.1146/annurev.iy.06.040188.000405. Annu Rev Immunol. 1988. PMID: 3289575 Review.
-
[The kallikrein-kininogen-kinin system: current concepts and perspectives].Ann Biol Clin (Paris). 1987;45(4):389-95. Ann Biol Clin (Paris). 1987. PMID: 3314606 Review. French. No abstract available.
Cited by
-
Acute effect of inhaled bradykinin on tracheobronchial clearance in normal humans.Thorax. 1992 Nov;47(11):952-6. doi: 10.1136/thx.47.11.952. Thorax. 1992. PMID: 1465754 Free PMC article. Clinical Trial.
-
Pharmacology of airway inflammation in asthma.Lung. 1990;168 Suppl:132-41. doi: 10.1007/BF02718126. Lung. 1990. PMID: 1974670 Review.
-
Bradykinin stimulates MMP-2 production in guinea pig tracheal smooth muscle cells.Inflammation. 2003 Oct;27(5):307-15. doi: 10.1023/a:1026080527573. Inflammation. 2003. PMID: 14635788
-
Elevated tissue kallikrein activity in airway secretions from patients with tracheobronchitis associated with prolonged mechanical ventilation.Lung. 2003;181(5):237-44. doi: 10.1007/s00408-003-1019-9. Lung. 2003. PMID: 14705767
-
Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies.Br J Pharmacol. 1991 Mar;102(3):774-7. doi: 10.1111/j.1476-5381.1991.tb12249.x. Br J Pharmacol. 1991. PMID: 1364852 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical